Representative before the EPO

Employment test 51 - 200 employees
Company dna mathys and squire llp
no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

Jane Harriet Evenson has worked on the following 66 EPO patent applications which have been published in the last five years:

EP10834963

HYPERSULFATED DISACCHARIDE FORMULATIONS

IPC classification:
A01N 43/04, A61K 31/715, A61P 11/00, A61P 11/06, A61P 11/08, A61P 29/00
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11763351

HYPERSULFATED GLUCOPYRANOSIDES

IPC classification:
A01N 43/16, A61K 31/34, A61K 31/35
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP12774724

ANTIBODIES AND OTHER MOLECULES THAT BIND B7-H1 AND PD-1

IPC classification:
A61K 39/395, C07K 16/28, C07K 16/30
Applicant:
MedImmune, LLC
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
Multiple attorneys, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP12797228

TREATMENT OF FRATAXIN (FXN) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO FXN

IPC classification:
C12N 15/113
Applicant:
CuRNA, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12804033

SIGNATURES AND DETERMINANTS ASSOCIATED WITH PROSTATE CANCER PROGRESSION AND METHODS OF USE THEREOF

IPC classification:
C12Q 1/68, G01N 33/574
Applicant:
Dana-Farber Cancer Institute, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10833923

TARGETED BINDING AGENTS AGAINST B7-H1

IPC classification:
C07K 16/28
Applicant:
MedImmune Limited
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
Multiple attorneys, MedImmune Limited
Status:
The patent has been granted
EP13178039

Process for preparing maytansinoid antibody conjugates

IPC classification:
A61K 47/48
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12829528

TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF SODIUM CHANNELS, VOLTAGE-GATED (SCNxA) WITH SMALL MOLECULES

IPC classification:
A61K 31/00, A61K 38/00
Applicant:
CuRNA, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12744250

METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION

IPC classification:
A61K 31/20, A61K 31/4015, A61P 25/28
Applicant:
Johns Hopkins University
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14163759

Methods for producing prepartions of recombinant AAVvirions substantially free of empty capsids

IPC classification:
B01D 15/00, B01D 15/04, C02F 1/42, C12N 7/02, C12N 15/864
Applicant:
Genzyme Corporation
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12856692

USE OF N-HYDROXYSUCCINIMIDE TO IMPROVE CONJUGATE STABILITY

IPC classification:
A61K 39/395
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP12842601

METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS

IPC classification:
A61K 38/18, A61P 7/06
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13707529

ANTI SEZ6 ANTIBODIES AND METHODS OF USE

IPC classification:
C07K 16/28
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13772302

METHODS AND COMPOSITIONS FOR INCREASING RED BLOOD CELLS

IPC classification:
A61K 38/19, A61P 7/06
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11837085

HYPERSULFATED DISACCHARIDES TO TREAT ELASTASE RELATED DISORDERS

IPC classification:
A01N 43/04, A61K 9/00, A61K 31/7016, A61K 31/715, A61K 45/06, A61K 47/36, A61P 11/00, A61P 11/08
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13744924

XYLOSE ISOMERASES AND THEIR USES

IPC classification:
C12N 9/90, C12N 15/10, C12P 7/10
Applicant:
BP Corporation North America Inc.
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13765550

BIOTIN COMPLEXES FOR TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE

IPC classification:
A61K 31/713, A61P 25/28, C12N 15/11, C12N 15/113
Applicant:
The General Hospital Corporation
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15154800

Inhibition of complement C5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection

IPC classification:
A61K 39/00, A61K 39/395, A61P 37/06, C07H 21/04, C07K 16/18, C12N 5/12, C12N 15/12
Applicant:
Genentech, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14195878

Notch1 receptor binding agents and methods of use thereof

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13771732

PEPTIDE-LINKED MORPHOLINO ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF MYOTONIC DYSTROPHY

IPC classification:
C12N 15/113
Applicant:
Genzyme Corporation
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13843881

USE OF AN ION EXCHANGE MEMBRANE TO REMOVE IMPURITIES FROM CELL-BINDING AGENT CYTOTOXIC AGENT CONJUGATES

IPC classification:
A23J 1/10, A61K 47/48, C07K 16/46
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13844268

USE OF A PVDF MEMBRANE TO PURIFY CELL-BINDING AGENT CYTOTOXIC AGENT CONJUGATES

IPC classification:
B01D 39/14, C12M 1/12
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12705776

NOVEL MODULATORS AND METHODS OF USE

IPC classification:
C07K 16/30
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
John William Graham Jappy, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP13854262

METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA

IPC classification:
A61K 31/445, A61K 31/55, A61K 31/662
Applicant:
Johns Hopkins University
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11734168

CONVERSION OF ALCOHOLS

IPC classification:
B01J 27/185, C07C 29/34, C07C 31/12
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
Elisabeth Anne Murray, BP International Ltd
Status:
APPLICATION WITHDRAWN
EP14704011

ANTI-TNF AND ANTI-IL17 COMBINATION THERAPY BIOMARKERS FOR INFLAMMATORY DISEASE

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
AbbVie Inc
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14749020

NOVEL MULTISPECIFIC CONSTRUCTS

IPC classification:
C12N 15/13
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP15169743

HUMAN MONOCLONAL ANTIBODIES TO ACTIVIN RECEPTOR-LIKE KINASE-1

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/40, C12N 5/12, C12N 15/13
Applicant:
Pfizer Inc
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11752429

NOTUM PROTEIN MODULATORS AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 16/22, C07K 16/40
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP14779587

METHODS OF DETECTING CANCER

IPC classification:
G01N 33/00, G01N 33/574
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14764293

METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION

IPC classification:
A61K 31/13
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14765419

METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION

IPC classification:
A61K 31/19
Applicant:
Johns Hopkins University
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14773017

MET-BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/18, C12P 21/08
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP11777719

TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A SIRTUIN (SIRT)

IPC classification:
C07H 19/00, C12N 15/11, C12N 15/63, C12Q 1/68
Applicant:
CuRNA, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15185710

TREATMENT OF 'C TERMINUS OF HSP70-INTERACTING PROTEIN' (CHIP) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO CHIP

IPC classification:
A61K 31/7088, A61K 48/00, A61P 25/00, A61P 37/00, C12N 15/113
Applicant:
CuRNA, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15176887

ALK7 POLYPEPTIDES FOR USE IN PROMOTING FAT LOSS

IPC classification:
A61K 38/17, A61P 21/06
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15178099

COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER

IPC classification:
A61K 39/395, A61P 35/00, C07K 14/475, C07K 14/705, C07K 16/28, C12N 15/12
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15198284

COMPOSITIONS OF TUMOR SPECIFIC NEOANTIGENS

IPC classification:
A61K 39/395, A61P 35/00, C07K 7/06, C07K 14/47, C12Q 1/68, G01N 33/50, G01N 33/53, G01N 33/68
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
The General Hospital Corporation
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
Robert Charles Dempster, Maschio & Soames IP Limited
Status:
EXAMINATION IN PROGRESS
EP16152143

INHIBITION OF COMPLEMENT C5 ACTIVATION FOR THE TREATMENT AND PREVENTION OF DELAYED XENOGRAFT OR ACUTE VASCULAR REJECTION

IPC classification:
A61K 39/00, A61K 39/395, A61P 37/06, C07H 21/04, C07K 16/18, C12N 5/12, C12N 15/12
Applicant:
Genentech, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15189425

ISOLATION AND PURIFICATION OF ANTI-IL-13 ANTIBODIES USING PROTEIN A AFFINITY CHROMATOGRAPHY

IPC classification:
A61K 39/395, C07K 16/06, C07K 16/24
Applicant:
AbbVie Inc
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14839285

SITE-SPECIFIC ANTIBODY CONJUGATION METHODS AND COMPOSITIONS

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/00, C12P 21/08
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14839261

ENGINEERED ANTI-DLL3 CONJUGATES AND METHODS OF USE

IPC classification:
A61K 47/48
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14839298

NOVEL SEZ6 MODULATORS AND METHODS OF USE

IPC classification:
A61K 38/00, A61K 39/395, A61P 35/00, C07K 16/28
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14837885

TGF-BETA RECEPTOR TYPE II VARIANTS AND USES THEREOF

IPC classification:
A61K 38/16, A61P 9/10, A61P 35/00, C07K 14/475, C07K 16/22, C07K 19/00
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11742761

METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION

IPC classification:
A01N 57/00, A61K 31/4015, A61K 31/445, A61K 31/66, A61K 45/06, A61P 25/28
Applicant:
Johns Hopkins University
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14821379

FORMULATIONS FOR NEOPLASIA VACCINES

IPC classification:
A61K 39/00
Applicant:
The Broad Institute, Inc.
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14870710

BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT

IPC classification:
C07D 237/26
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14874789

IMMUNOTHERAPY WITH BINDING AGENTS

IPC classification:
C07K 16/28
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16164549

ANTI DLL3 ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
A61K 47/48, A61P 35/00, C07K 14/47, C07K 16/28, C07K 16/30
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP16164551

DLL3 MODULATORS AND METHODS OF USE

IPC classification:
A61K 47/48, A61P 35/00, C07K 14/47, C07K 16/28, C07K 16/30
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP16164567

ANTI DLL3 ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
A61K 47/48, A61P 35/00, C07K 14/47, C07K 16/28, C07K 16/30
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15752054

ANTI-DLL3 ANTIBODIES AND DRUG CONJUGATES FOR USE IN MELANOMA

IPC classification:
A61K 39/395, A61K 47/48, G01N 33/574
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15758330

METHODS FOR TREATING CANCER WITH NOTCH1 ANTIBODIES

IPC classification:
A61K 39/395, C12Q 1/68, G01N 33/574
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16186033

COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS

IPC classification:
A61K 38/00, A61P 7/06, C07K 14/71
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP15765863

METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS BY INHIBITING ACTIVIN B AND/OR GDF11

IPC classification:
A61K 31/7088, A61K 38/18, A61K 39/395, A61P 7/06
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15779814

METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING SICKLE-CELL DISEASE

IPC classification:
A61K 38/17, A61K 38/18, A61P 7/06, C07K 16/22, C07K 16/46
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15785217

POLYFLUORINATED COMPOUNDS ACTING AS BRUTON'S TYROSINE KINASE INHIBITORS

IPC classification:
A61K 31/519, A61P 1/04, A61P 3/10, A61P 5/20, A61P 21/04, A61P 37/02, C07C 43/29, C07C 45/29, C07C 49/813, C07C 303/38, C07C 311/08, C07D 213/81, C07D 215/22, C07D 215/233, C07D 239/34, C07D 487/04, C07D 519/00, C07F 5/04
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15806256

METHODS AND COMPOSITIONS FOR TREATING ULCERS

IPC classification:
A61K 38/18, A61K 39/395, A61P 17/02, C07K 19/00
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15802909

METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS WITH FOLLISTATIN POLYPEPTIDES

IPC classification:
A61K 38/16, A61P 21/06, C07K 19/00, C12N 15/62
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15837897

NOVEL ANTI-MFI2 ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 45/00, C07K 16/18, C12P 21/08
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP15775545

USE OF CLONAL EVOLUTION ANALYSIS FOR IBRUTINIB RESISTANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

IPC classification:
C12Q 1/68
Applicant:
The Board of Regents of the University of Texas System
Applicant:
President and Fellows of Harvard College
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP15847978

HIV VACCINES COMPRISING ONE OR MORE POPULATION EPISENSUS ANTIGENS

IPC classification:
A61K 39/21, A61P 31/18
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP16195379

ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF FOR REGULATING BODY FAT CONTENT

IPC classification:
A61K 31/663, A61K 38/17, A61K 38/18, A61P 19/08, A61P 19/10, A61P 21/00, C07K 14/705, A61K 47/51
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
The application has been published
EP15854065

METHODS AND COMPOSITIONS USING GDF15 POLYPEPTIDES FOR INCREASING RED BLOOD CELLS

IPC classification:
A61K 38/18, A61P 7/06
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP15857690

ANTI-CLDN CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE

IPC classification:
A61P 35/00, C07K 14/725, C07K 16/28
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made
EP15865103

METHODS FOR TREATING MYELODYSPLASTIC SYNDROMES AND SIDEROBLASTIC ANEMIAS

IPC classification:
A61K 38/18, A61K 39/395, A61P 7/06
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Status:
Request for examination was made

Please Sign in to use this feature